1 |
Stone J, Wojcik W, Durrance D, et al. What should we say to patients with symptoms unexplained by disease? The "number needed to offend". BMJ 2002;325:1449-1450.
DOI
|
2 |
Lipowski ZJ. Somatization: the concept and its clinical application. Am J Psychiatry 1988;145:1358-1368.
DOI
|
3 |
Galli S, Tatu L, Bogousslavsky J, Aybek S. Conversion, factitious disorder and malingering: a distinct pattern or a continuum? Front Neurol Neurosci 2018;42:72-80.
DOI
|
4 |
Mayou R, Kirmayer LJ, Simon G, Kroenke K, Sharpe M. Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry 2005;162:847-855.
DOI
|
5 |
Ghanizadeh A, Firoozabadi A. A review of somatoform disorders in DSM-IV and somatic symptom disorders in proposed DSM-V. Psychiatr Danub 2012;24:353-358.
|
6 |
American Psychiatric Association Division of Research. Highlights of changes from DSM-IV to DSM-5: somatic symptom and related disorders. FOCUS 2013;11:525-527.
DOI
|
7 |
American Psychiatric Association. Diagnostic and Statistical Manual (DSM) of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
|
8 |
Landa A, Peterson BS, Fallon BA. Somatoform pain: a developmental theory and translational research review. Psychosom Med 2012;74:717-727.
DOI
|
9 |
Gundel H, Valet M, Sorg C, et al. Altered cerebral response to noxious heat stimulation in patients with somatoform pain disorder. Pain 2008;137:413-421.
DOI
|
10 |
Limer KL, Nicholl BI, Thomson W, McBeth J. Exploring the genetic susceptibility of chronic widespread pain: the tender points in genetic association studies. Rheumatology (Oxford) 2008;47:572-577.
DOI
|
11 |
Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002;46:1333-1343.
DOI
|
12 |
Moles A, Kieffer BL, D'Amato FR. Deficit in attachment behavior in mice lacking the mu-opioid receptor gene. Science 2004;304:1983-1986.
DOI
|
13 |
Derogatis LR. SCL-90-R: administration, scoring & procedures manual-II. Towson: Clinic Psychometric Research; 1983. pp. 14-15.
|
14 |
Melis M, Zawawi KH. Occlusal dysesthesia: a topical narrative review. J Oral Rehabil 2015;42:779-785.
DOI
|
15 |
Imhoff B, Ahlers MO, Hugger A, et al. Occlusal dysesthesia- a clinical guideline. J Oral Rehabil 2020;47:651-658.
DOI
|
16 |
Hara ES, Matsuka Y, Minakuchi H, Clark GT, Kuboki T. Occlusal dysesthesia: a qualitative systematic review of the epidemiology, aetiology and management. J Oral Rehabil 2012;39:630-638.
DOI
|
17 |
Reeves JL 2nd, Merrill RL. Diagnostic and treatment challenges in occlusal dysesthesia. J Calif Dent Assoc 2007;35:198-207.
|
18 |
Malacarne A, Spierings ELH, Lu C, Maloney GE. Persistent dentoalveolar pain disorder: a comprehensive review. J Endod 2018;44:206-211.
DOI
|
19 |
McBeth J, Macfarlane GJ, Benjamin S, Silman AJ. Features of somatization predict the onset of chronic widespread pain: results of a large population-based study. Arthritis Rheum 2001;44:940-946.
DOI
|
20 |
Herrero Babiloni A, Nixdorf DR, Moana-Filho EJ. Persistent dentoalveolar pain disorder: a putative intraoral chronic overlapping pain condition. Oral Dis 2020;26:1601-1609.
DOI
|
21 |
Mayou R, Bass C, Sharpe M. Overview of epidemiology, classification, and aetiology. In: Mayou R, Bass C, Sharpe M, eds. Treatment of functional somatic symptoms. London: Oxford University Press; 1995. pp. 42-65.
|
22 |
Sayar K, Ak I. The predictors of somatization: a review. Psychiatry Clin Psychopharmacol 2001;11:266-271.
|
23 |
Craig AD. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci 2002;3:655-666.
DOI
|
24 |
Themessl-Huber M. Weak evidence supports the use of psychosocial interventions for chronic orofacial pain. Evid Based Dent 2012;13:58.
DOI
|
25 |
Barker S, Urbanek M, Penlington C. Psychological interventions for persistent orofacial pain. Prim Dent J 2019;7:30-35.
|
26 |
Aggarwal VR, Lovell K, Peters S, Javidi H, Joughin A, Goldthorpe J. Psychosocial interventions for the management of chronic orofacial pain. Cochrane Database Syst Rev 2008;205(E6):1-6. Update in: Cochrane Database Syst Rev 2011;(11):CD008456.
|
27 |
Litt MD, Shafer DM, Kreutzer DL. Brief cognitive-behavioral treatment for TMD pain: long-term outcomes and moderators of treatment. Pain 2010;151:110-116.
DOI
|
28 |
Turk DC, Rudy TE, Kubinski JA, Zaki HS, Greco CM. Dysfunctional patients with temporomandibular disorders: evaluating the efficacy of a tailored treatment protocol. J Consult Clin Psychol 1996;64:139-146.
DOI
|
29 |
Dworkin SF, Turner JA, Wilson L, et al. Brief group cognitive-behavioral intervention for temporomandibular disorders. Pain 1994;59:175-187.
DOI
|
30 |
Flor H, Birbaumer N. Comparison of the efficacy of electromyographic biofeedback, cognitive-behavioral therapy, and conservative medical interventions in the treatment of chronic musculoskeletal pain. J Consult Clin Psychol 1993;61:653-658.
DOI
|
31 |
De La Torre Canales G, Camara-Souza MB, Munoz Lora VRM, et al. Prevalence of psychosocial impairment in temporomandibular disorder patients: a systematic review. J Oral Rehabil 2018;45:881-889.
DOI
|
32 |
Engel GL. The need for a new medical model: a challenge for biomedicine. Psychodyn Psychiatry 2012;40:377-396.
DOI
|
33 |
Ohrbach R, Dworkin SF. The evolution of TMD diagnosis: past, present, future. J Dent Res 2016;95:1093-1101.
DOI
|
34 |
Noma N, Watanabe Y, Shimada A, et al. Effects of cognitive behavioral therapy on orofacial pain conditions. J Oral Sci 2020;63:4-7.
DOI
|
35 |
Turner JA, Dworkin SF, Mancl L, Huggins KH, Truelove EL. The roles of beliefs, catastrophizing, and coping in the functioning of patients with temporomandibular disorders. Pain 2001;92:41-51.
DOI
|
36 |
Quill TE. Recognizing and adjusting to barriers in doctor-patient communication. Ann Intern Med 1989;111:51-57.
DOI
|
37 |
Fillingim RB, Ohrbach R, Greenspan JD, et al. Psychological factors associated with development of TMD: the OPPERA prospective cohort study. J Pain 2013;14(12 Suppl):T75-T90.
DOI
|
38 |
Lynch DJ, McGrady AV, Nagel RW, Wahl EF. The patient-physician relationship and medical utilization. Prim Care Companion J Clin Psychiatry 2007;9:266-270.
DOI
|
39 |
Steinmetz D, Tabenkin H. The 'difficult patient' as perceived by family physicians. Fam Pract 2001;18:495-500.
DOI
|
40 |
Fillingim RB, Ohrbach R, Greenspan JD, et al. Potential psychosocial risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. J Pain 2011;12(11 Suppl):T46-T60.
DOI
|
41 |
Maixner W, Diatchenko L, Dubner R, et al. Orofacial pain prospective evaluation and risk assessment study--the OPPERA study. J Pain 2011;12(11 Suppl):T4-T11.e1-e2.
DOI
|
42 |
Ohrbach R, Durham J. Biopsychosocial aspects of orofacial pain. In: Farah C, Balasubramaniam R, McCullough M, eds. Contemporary oral medicine. Cham: Springer; 2017. pp. 1-21.
|
43 |
Lipowski ZJ. Somatization: a borderland between medicine and psychiatry. CMAJ 1986;135:609-614.
|
44 |
Kirmayer LJ. Culture, affect and somatization: part I. Transcult Psychiatr Res Rev 1984;21:159-188.
DOI
|
45 |
Giesecke T, Gracely RH, Grant MA, et al. Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 2004;50:613-623.
DOI
|
46 |
Baad-Hansen L, Pigg M, Ivanovic SE, et al. Intraoral somatosensory abnormalities in patients with atypical odontalgia--a controlled multicenter quantitative sensory testing study. Pain 2013;154:1287-1294.
DOI
|
47 |
Crider AB, Glaros AG. A meta-analysis of EMG biofeedback treatment of temporomandibular disorders. J Orofac Pain 1999;13:29-37.
|
48 |
Liu J, Gill NS, Teodorczuk A, Li ZJ, Sun J. The efficacy of cognitive behavioural therapy in somatoform disorders and medically unexplained physical symptoms: a meta-analysis of randomized controlled trials. J Affect Disord 2019;245:98-112.
DOI
|
49 |
Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992;6:301-355.
|
50 |
Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for clinical and research applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†. J Oral Facial Pain Headache 2014;28:6-27.
DOI
|
51 |
Slade GD, Ohrbach R, Greenspan JD, et al. Painful temporomandibular disorder: decade of discovery from OPPERA studies. J Dent Res 2016;95:1084-1092.
DOI
|
52 |
Manfredini D, Ahlberg J, Winocur E, Guarda-Nardini L, Lobbezoo F. Correlation of RDC/TMD axis I diagnoses and axis II pain-related disability. A multicenter study. Clin Oral Investig 2011;15:749-756.
DOI
|